Adverse Drug Reaction News Bulletins
ADR News Bulletin 2023 September (Volume 25 Number 2)
22 September 2023
Audiences
Healthcare professional
Industry member
Product-type
Therapeutic Products
This article has been migrated from an earlier version of the site and may display formatting inconsistencies.
Bulletin Highlights:
Reminder on the risk of pholcodine-associated perioperative anaphylaxis with neuromuscular blocking agents
Biotin interference with thyroid function tests
HSA is assessing the potential risk of suicidal thoughts and self-harm with glucagon-like peptide-1 receptor agonists (GLP-1 RA)
Reports of issues associated with the use of Cathejell (lignocaine 2% gel)
Click on the link below to download the issue in pdf: